BRO Stock Forecast & Price Target

Brown & Brown is supported by a durable brokerage model that should benefit as property-rate pressure eases, with Retail organic growth excluding contingents expected to improve from 1.2% in 1H26 to 1.5-2.5% in 2H26 and Specialty Distribution rebounding from a (2.7)% decline in 1H26 to 2-4% in 2H26. The Accession acquisition broadens its reach in agriculture, healthcare, private equity, reinsurance, and captives, while targeting $150 million of run-rate synergies by year-end 2028 and lifting 1H26 adjusted EBITDAC margin to 37.2%, above the raised long-term range of 32-37%. Strong buyback capacity, roughly $900 million in 2026E and another $800 million in 2027E, combines with underused cross-sell and vertical-integration opportunities to support earnings growth, valuation support, and a rerating versus peers.

Brown & Brown is facing a deteriorating pricing backdrop, with property CAT rates still down 15%-35% and casualty now softening in 2Q26 as pricing in many areas fails to keep pace with loss costs. Its heavy exposure to property and commission-based revenue makes it especially vulnerable to lower premium rates and potential carrier commission cuts, which have already contributed to five organic growth misses in six quarters despite adjusted EPS beats. The outlook is further pressured by 275 employees poached, a $50-60 million estimated 2026 revenue hit, intense competition for talent and acquisitions, and larger peers moving into the middle market, all of which threaten organic growth and margins.